Cassava Sciences, Inc.

SAVA

$3.98

Name : Cassava Sciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $192,265,424.00

EPSttm : -2.63

Cassava Sciences, Inc.

$3.98

16.37%

$0.56

Float Short %

14.12

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

3.99

Target Price

Analyst Recom

Performance Q

84.26

Relative Volume

2.17

Beta

-1.12

Ticker: SAVA

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	SAVA	2.14	0.12	0.72	54706
2025-09-09	SAVA	2.17	0.13	0.20	54922
2025-09-10	SAVA	2.1	0.12	0.20	55004
2025-09-11	SAVA	2.17	0.13	0.31	55213
2025-09-12	SAVA	2.11	0.13	0.20	55361
2025-09-15	SAVA	2.09	0.13	0.13	55201
2025-09-16	SAVA	2.1	0.13	0.79	55574
2025-09-17	SAVA	2.08	0.12616255560049	0.16298342541436	55700
2025-09-18	SAVA	2.28	0.12	0.05	55967
2025-09-19	SAVA	2.3	0.12	0.20	57526
2025-09-22	SAVA	2.33	0.12	0.63	56018
2025-09-23	SAVA	3.42	0.12	0.15	56776
2025-09-24	SAVA	3.26	0.16	0.24	82810
2025-09-25	SAVA	3.1	0.16	0.23	83648
2025-09-26	SAVA	3	0.17	1.09	82954
2025-09-29	SAVA	3.15	0.15	0.24	71716
2025-09-30	SAVA	2.89	0.15	0.28	73466
2025-10-01	SAVA	3.19	0.15	0.05	74803
2025-10-02	SAVA	3.43	0.15	0.26	77426
2025-10-03	SAVA	3.64	0.15	0.18	79980
2025-10-06	SAVA	3.58	0.15	0.51	74678
2025-10-07	SAVA	3.43	0.18	0.12	78061
2025-10-08	SAVA	3.98	0.18	0.07	78157
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	SAVA	2.14	-	-	-
2025-09-09	SAVA	2.17	-	-	-
2025-09-10	SAVA	2.11	-	-	-
2025-09-11	SAVA	2.16	-	-	-
2025-09-12	SAVA	2.11	-	-	-
2025-09-15	SAVA	2.09	-	-	-
2025-09-16	SAVA	2.09	-	-	-
2025-09-17	SAVA	2.08	-	-	-
2025-09-18	SAVA	2.28	-	-	-
2025-09-19	SAVA	2.30	-	-	-
2025-09-22	SAVA	2.32	-	-	-
2025-09-23	SAVA	3.42	-	-	-
2025-09-24	SAVA	3.26	-	-	-
2025-09-25	SAVA	3.10	-	-	-
2025-09-26	SAVA	2.99	-	-	-
2025-09-29	SAVA	3.15	-	-	-
2025-09-30	SAVA	2.90	-	-	-
2025-10-01	SAVA	3.19	-	-	-
2025-10-02	SAVA	3.44	-	-	-
2025-10-03	SAVA	3.65	-	-	-
2025-10-06	SAVA	3.58	-	-	-
2025-10-07	SAVA	3.43	-	-	-
2025-10-08	SAVA	3.99	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	SAVA	0.00	-21.98	14.87
2025-09-09	SAVA	0.00	-21.98	14.87
2025-09-10	SAVA	0.00	-21.98	14.87
2025-09-11	SAVA	0.00	-21.98	14.60
2025-09-12	SAVA	0.00	-21.98	14.60
2025-09-15	SAVA	0.00	-21.88	14.60
2025-09-16	SAVA	0.00	-21.88	14.60
2025-09-17	SAVA	0.00	-21.88	14.60
2025-09-18	SAVA	0.00	-21.88	14.60
2025-09-19	SAVA	0.00	-21.88	14.60
2025-09-22	SAVA	3.90	-21.89	14.60
2025-09-23	SAVA	4.03	-21.89	14.60
2025-09-24	SAVA	4.03	-21.89	14.60
2025-09-25	SAVA	4.03	-21.89	14.03
2025-09-26	SAVA	4.03	-21.89	14.03
2025-09-29	SAVA	4.03	-21.89	14.11
2025-09-30	SAVA	3.87	-21.89	14.11
2025-10-01	SAVA	3.87	-21.89	14.11
2025-10-02	SAVA	3.87	-21.89	14.11
2025-10-03	SAVA	4.09	-21.89	14.11
2025-10-06	SAVA	4.10	-9.19	14.11
2025-10-07	SAVA	4.10	-9.19	14.12
2025-10-08	SAVA	4.09	-9.19	14.12
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.68

Avg. EPS Est. Next Quarter

Insider Transactions

4.09

Institutional Transactions

-9.19

Beta

-1.12

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.3

Max Drawdown 5-Year %

-99.1

Target Price

P/E

Forward P/E

PEG

P/S

P/B

2.19

P/Free Cash Flow

EPS

-2.56

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2.17

Return on Equity vs Sector %

-165.2

Return on Equity vs Industry %

-151.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Cassava Sciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 30

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

stock quote shares SAVA – Cassava Sciences, Inc. Stock Price stock today

news today SAVA – Cassava Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SAVA – Cassava Sciences, Inc. yahoo finance google finance

stock history SAVA – Cassava Sciences, Inc. invest stock market

stock prices SAVA premarket after hours

ticker SAVA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SAVA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y